Stem Cell Manufacturing Market trends and outlook 2021-28

Author : Alisha Sahani | Published On : 01 Sep 2021

The stem cell manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.1% in the forecast period of 2021 to 2028 and is expected to reach USD 23,505.08 million by 2028 from USD 11,076.78 million in 2020. The rising prevalence of cancer and stem cell transplant, growth of novel technological advancements for stem cell transplant is likely to be the major drivers which propel the demand of the market in the forecast period.

Stem cells are body's raw material that can differentiate into a variety of cells. It means cells from which all other cells with specialized functions are generated. Stem Cell therapies are defined as treatment for a medical condition that involves the use of any type of human stem cells including embryonic stem cells, adult stem cells for allogeneic and autologous therapies.



Download Sample Report @



The major companies providing global stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.


Get Details TOC @



Global Stem Cell Manufacturing Market Scope and Market Size

The global stem cell manufacturing market is categorized into four notable segments which are based on products, application, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Based on products, the global stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, the consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies

Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking, and others. In 2021, the research applications segment is expected to dominate the market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.

View complete report @


Customization Available: Global Stem Cell Manufacturing Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Browse related report @   Breast Pumps Market 

                                          C-Arms Market

                                          CADASIL treatment market

                                          Candidiasis Therapeutics Market

                                          Cardiac Rehabilitation Market